Division of Cardiology, Careggi Hospital, Florence, Italy.
Am J Cardiol. 2013 Dec 15;112(12):1849-53. doi: 10.1016/j.amjcard.2013.08.012. Epub 2013 Sep 21.
No data exist about successful percutaneous coronary intervention (PCI) and clinical outcome in patients with multiple coronary chronic total occlusions (CTOs). The aim of this study was to determine the impact on cardiac mortality of PCI of multiple CTOs. The Florence CTO PCI registry includes patients treated with drug-eluting stent for at least 1 CTO. From this registry, we examined consecutive patients with ≥2 CTOs. Patients were stratified into successful PCI of all attempted CTOs and partially successful PCI (1 CTO PCI successful) or failed PCI (no CTO PCI success) groups. The primary end point of the study was cardiac mortality. Of 1,035 patients with CTO, 120 (11.6%) underwent PCI for ≥2 CTOs for a total of 249 CTOs. CTO PCI was successful in 195 CTOs (78.3%), and in 76 patients (63.3%), PCI was successful in all attempted lesions, whereas in 34 patients, CTO PCI was partially successful and in 10, completely unsuccessful. Cardiac mortality at 12 months was lower in the CTO PCI success group than CTO PCI failure or partial success group (1.3% vs 11.3%; p = 0.025). The 2-year survival rate was lower in patients with a complete coronary revascularization compared with those with incomplete revascularization (96 ± 3% vs 78 ± 7%; p = 0.002); completeness of revascularization was inversely related to the risk of death (hazard ratio 0.10; p = 0.029). In patients with multiple CTOs, a successful PCI of all CTOs was associated with increased survival and completeness of revascularization was a strong predictor of survival.
目前尚无关于经皮冠状动脉介入治疗(PCI)和多发性冠状动脉慢性完全闭塞(CTO)患者临床转归的数据。本研究旨在确定PCI 治疗多发性 CTO 对心脏死亡率的影响。佛罗伦萨 CTO PCI 注册研究包括至少接受 1 个 CTO 药物洗脱支架治疗的患者。本研究入选了该注册研究中的连续患者,这些患者患有≥2 个 CTO。患者分为所有尝试 CTO 均成功 PCI 和部分成功 PCI(1 个 CTO PCI 成功)或失败 PCI(无 CTO PCI 成功)两组。研究的主要终点为心脏死亡率。在 1035 例 CTO 患者中,有 120 例(11.6%)接受了至少 2 个 CTO 的 PCI,共涉及 249 个 CTO。195 个 CTO 的 PCI 获得成功(78.3%),76 例(63.3%)患者的所有尝试病变 PCI 均成功,34 例患者的 CTO PCI 部分成功,10 例患者的 CTO PCI 完全失败。12 个月时,CTO PCI 成功组的心脏死亡率低于 CTO PCI 失败或部分成功组(1.3% vs. 11.3%;p=0.025)。与不完全血运重建患者相比,完全血运重建患者的 2 年生存率更低(96 ± 3% vs. 78 ± 7%;p=0.002);血运重建的完整性与死亡风险呈反比(风险比 0.10;p=0.029)。在多发性 CTO 患者中,所有 CTO 的成功 PCI 与生存率增加相关,而血运重建的完整性是生存率的强有力预测因素。